Stock listing

Abbott Laboratories

Selected listing: ABL · BX · CHF · CH

Abbott Laboratories (BX Swiss: ABL), Health Technology. Latest release Oct 5, 2026: Abbott receives FDA approval for new CardioMEMS HF System capabilities…

ABL:BXCHFCHUpdated October 2, 2026

Ticker: BX Swiss: ABL
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: BX Swiss
Currency: CHF

Latest news from Abbott Laboratories

Abbott receives FDA approval for new CardioMEMS HF System capabilities that help patients engage in the care of their heart condition

October 5, 2026

Abbott launches SimpleScreen™ CRC blood test, joining Cologuard Plus® in its colorectal cancer screening portfolio

September 30, 2026

Abbott Laboratories : Landmark study in people with Type 2 diabetes using basal insulin shows continuous glucose monitoring, including Abbott’s Libre technology, associated with lower risk of death and cardiovascular complications

September 24, 2026

Abbott And Berry Street Partner To Expand Personalized Nutrition Support For Consumers Seeking Better Metabolic Health

September 23, 2026

Abbott declares 411th consecutive quarterly dividend

September 17, 2026

All Abbott Laboratories news →

Events

Replays

Abbott Laboratories (ABT) Q2 2026 Earnings Call
Thu, Jul 16, 2026 · 09:00 AM ET
Watch
Abbott Laboratories (ABT) Q1 2026 Earnings Call
Thu, Apr 16, 2026 · 09:00 AM ET
Watch
Abbott Laboratories (ABT) Q4 2025 Earnings Call
Thu, Jan 22, 2026 · 09:00 AM ET
Watch

Research Abbott Laboratories

Abbott Laboratories company profile

View the public company page for Abbott Laboratories on 6ix.

Abbott Laboratories news

Read company news and market updates connected to Abbott Laboratories.

Abbott Laboratories investor events

Find investor webinars, events, and replay context for Abbott Laboratories.